BRAF and melanoma: V600E mutation in the kinase domain of B-Raf protein accounted for 66% of melanoma, 40–70% of papillary thyroid carcinoma, 12% of colon carcinomas, and 14% of liver cancers (Yuen et al. 2002, ET et al. 2003, El-Damasy et al. 2020).